Neural complexity as a potential translational biomarker for psychosis
Brandon M. HagerMassachusetts Mental Health Center, Boston, MA, USA; Division of Public Psychiatry, Beth Israel Deaconess Medical Center/Department of Psychiatry, Harvard Medical School, Boston, MA, USAAlbert C. YangDivision of Interdisciplinary Medicine and Biotechnology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA; Department of Psychiatry, Taipei Veterans General Hospital/School of Medicine, National Yang-Ming University, Taipei, TaiwanRoscoe O. BradyMassachusetts Mental Health Center, Boston, MA, USA; Division of Public Psychiatry, Beth Israel Deaconess Medical Center/Department of Psychiatry, Harvard Medical School, Boston, MA, USAShashwath A. MedaDepartments of Psychiatry and Neuroscience, Yale University School of Medicine, New Haven, and the Institute of Living, Hartford Hospital, Hartford, CT, USABrett A. ClementzDepartments of Psychology and Neuroscience, Bio-Imaging Research Center, University of Georgia, Athens, USAGodfrey D. PearlsonYale UniversityJohn A. SweeneyDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati School of Medicine, Cincinnati, OH, USACarol A. TammingaDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, USAMatcheri S. KeshavanMassachusetts Mental Health Center, Boston, MA, USA; Division of Public Psychiatry, Beth Israel Deaconess Medical Center/Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: [email protected]
2016en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references